Display options
Cite
Hickey SM, Ashton TD, White JM, et al. Synthesis of Norbornane Bisether Antibiotics via Silver-mediated Alkylation. RSC Adv. 2015;5:28582-28596doi: 10.1039/C5RA03321G.
Hickey, S. M., Ashton, T. D., White, J. M., Li, J., Nation, R. L., Yu, H. Y., Elliott, A. G., Butler, M. S., Huang, J. X., Cooper, M. A., & Pfeffer, F. M. (2015). Synthesis of Norbornane Bisether Antibiotics via Silver-mediated Alkylation. RSC advances, 528582-28596. https://doi.org/10.1039/C5RA03321G
Hickey, Shane M, et al. "Synthesis of Norbornane Bisether Antibiotics via Silver-mediated Alkylation." RSC advances vol. 5 (2015): 28582-28596. doi: https://doi.org/10.1039/C5RA03321G
Hickey SM, Ashton TD, White JM, Li J, Nation RL, Yu HY, Elliott AG, Butler MS, Huang JX, Cooper MA, Pfeffer FM. Synthesis of Norbornane Bisether Antibiotics via Silver-mediated Alkylation. RSC Adv. 2015;5:28582-28596. doi: 10.1039/C5RA03321G. PMID: 26251697; PMCID: PMC4523246.
Copy Download .nbib Format: NLM
Share it on

RSC Adv. 2015;5:28582-28596. doi: 10.1039/C5RA03321G.

Synthesis of Norbornane Bisether Antibiotics via Silver-mediated Alkylation.

RSC advances

Shane M Hickey, Trent D Ashton, Jonathan M White, Jian Li, Roger L Nation, Heidi Y Yu, Alysha G Elliott, Mark S Butler, Johnny X Huang, Matthew A Cooper, Frederick M Pfeffer

Affiliations

  1. Research Centre for Chemistry and Biotechnology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, Victoria, 3216, Australia.
  2. Bio21 Institute, School of Chemistry, University of Melbourne, Parkville, Victoria, 3010, Australia.
  3. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Science, Royal Parade, Parkville, Victoria, 3052, Australia.
  4. Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, 4072, Australia.

PMID: 26251697 PMCID: PMC4523246 DOI: 10.1039/C5RA03321G

Abstract

A small series of norbornane bisether diguanidines have been synthesized and evaluated as antibacterial agents. The key transformation-bisalkylation of norbornane diol

References

  1. Clin Infect Dis. 2006 Mar 1;42(5):657-68 - PubMed
  2. J Med Chem. 1997 Jun 6;40(12):1773-8 - PubMed
  3. J Org Chem. 1997 Oct 17;62(21):7512-7515 - PubMed
  4. Chem Commun (Camb). 2008 Apr 28;(16):1871-3 - PubMed
  5. J Med Chem. 2011 Apr 14;54(7):2241-54 - PubMed
  6. J Antibiot (Tokyo). 2013 Oct;66(10):571-91 - PubMed
  7. Org Lett. 2014 Oct 3;16(19):5120-3 - PubMed
  8. J Med Chem. 2006 Dec 28;49(26):7754-65 - PubMed
  9. J Am Chem Soc. 2004 Oct 27;126(42):13642-8 - PubMed
  10. J Infect. 2009 Feb;58(2):138-44 - PubMed
  11. Eur J Biochem. 1996 May 1;237(3):575-83 - PubMed
  12. J Org Chem. 2012 Oct 5;77(19):8507-17 - PubMed
  13. Acc Chem Res. 2013 Apr 16;46(4):967-78 - PubMed
  14. Bioorg Med Chem Lett. 1998 Dec 15;8(24):3647-8 - PubMed
  15. Nature. 2011 Apr 7;472(7341):32 - PubMed
  16. Eur J Med Chem. 2011 Sep;46(9):4201-11 - PubMed
  17. J Org Chem. 2010 Jun 4;75(11):3775-80 - PubMed
  18. Chem Commun (Camb). 2010 May 14;46(18):3197-9 - PubMed
  19. Chem Commun (Camb). 2003 Jun 21;(12):1440-1 - PubMed
  20. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9768-72 - PubMed
  21. Chem Commun (Camb). 2011 May 28;47(20):5849-51 - PubMed
  22. Acc Chem Res. 2007 Oct;40(10):1057-65 - PubMed
  23. Chem Commun (Camb). 2013 Apr 28;49(33):3376-88 - PubMed
  24. J Org Chem. 2007 Jul 20;72(15):5920-2 - PubMed
  25. Clin Infect Dis. 2009 Jan 1;48(1):1-12 - PubMed
  26. Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22 - PubMed
  27. Bioorg Med Chem. 2002 Apr;10(4):1115-22 - PubMed

Publication Types

Grant support